NASDAQ:DRMAW

Dermata Therapeutics Stock Forecast

etoro logo Buy DRMAW
*Your capital is at risk
$0.0089
-0.0029 (-24.58%)
At Close: Jul 16, 2026
AI Analysis AI Analysis of DRMAW AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add DRMAW to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Dermata Therapeutics, Inc. stock price on Thursday moving 186.25% between high and low
(Updated on Jul 16, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 16, 2026

The Dermata Therapeutics, Inc. stock price fell by -24.58% on the last day (Thursday, 16th Jul 2026) from $0.0118 to $0.0089. During the last trading day the stock fluctuated 186.25% from a day low at $0.0080 to a day high of $0.0229. The price has fallen in 5 of the last 10 days and is down by -29.37% for this period. Volume has increased on the last day by 40 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 45 thousand shares were bought and sold for approximately $398.94 .

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0083 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -21.80% during the next 3 months and, with a 90% probability hold a price between $0.0065 and $0.0104 at the end of this 3-month period.

DRMAW Signals & Forecast

There are few to no technical positive signals at the moment. The Dermata Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0118 and $0.0126. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 01, 2026, and so far it has fallen -29.37%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Dermata Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Tuesday, June 30, 2026 and based on theory for this formation the price should go up by 25.64% to $0.0112 within 11 trading days (Thursday, July 16, 2026) since signal was issued.

Support, Risk & Stop-loss for Dermata Therapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0149 between high and low, or 186.25%. For the last week, the stock has had daily average volatility of 59.42%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (DRMAW) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect Dermata Therapeutics, Inc. to open at $0.0133, and during the day (based on 14 day Average True Range), to move between $0.0069 and $0.0109, which gives a possible trading interval of +/-$0.0040 (+/-57.89%) up or down from last closing price. If Dermata Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 57.89% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.0102, some $0.0013 (14.61%) from the current price of $0.0089, our system finds the risk reward not very attractive.

Is Dermata Therapeutics, Inc. stock A Buy?

Dermata Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Sell candidate.

Current score: -8.345 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 17, 2026 - $0.0133 ( 49.06%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

DRMAW Performance

Trading levels for DRMAW

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0282 216.48%
R2 0.0225 152.53%
R1 0.0190 113.02%
Price 0.0089
S1 0.0076 -14.89%
S2 0.0041 -54.40%
S3 -0.0016 -118.35%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0.0110 23.60%
R1 0.0102 14.61%
Price 0.0089
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Dermata Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Dermata Therapeutics, Inc. is DRMAW and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Dermata Therapeutics, Inc. Stock?
Dermata Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Sell candidate.

How to buy Dermata Therapeutics, Inc. Stock?
Dermata Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Dermata Therapeutics, Inc. Stock.

What's the current price of Dermata Therapeutics, Inc. Stock?
As of the end of day on the Jul 16, 2026, the price of an Dermata Therapeutics, Inc. (DRMAW) share was $0.0089.

What is the 52-week high and low for Dermata Therapeutics, Inc. Stock?
The 52-week high for Dermata Therapeutics, Inc. Stock is $0.0290 and the 52-week low is $0.0080.

What is the market capitalization of Dermata Therapeutics, Inc. Stock?
As of the Jul 16, 2026, the market capitalization of Dermata Therapeutics, Inc. is 6.066K.

When is the next earnings date for Dermata Therapeutics, Inc.?
The upcoming earnings date for Dermata Therapeutics, Inc. is Aug 18, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.06% Jul 13
SRPT
$17.02
1.23% Jun 29
NMRK
$15.02
5.86% Jun 24
X
XMAX
$8.34
2.28% Jun 24
JLL
$299.78
12.03% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE